C09 (A1)
Gender: Male and Female
Smoking habit: Non / Ex-smoker only
Pot smoking
18 - 55
BMI : 18.50 - 30.00
Food restrictions : Fast
Clinic stay
- 18 Nov (17:30) to 22 Nov (09:00)
- 2 Dec (17:30) to 6 Dec (09:00)
- 16 Dec (17:30) to 20 Dec (09:00)
Return visits
- 2 Jan (08:00)
Participants must be available to stay at our clinic for all of the dates listed above and/or in the notes below. All clinic stays and return visits are mandatory. Times are subject to change.
Medication type
This drug is an anti-inflammatory and immunosuppressive medication used by patients who suffer from Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).
Notes
Participants who have a tongue piercing are not eligible.
Phase 1 study.
Minimum weight: 50 kg.
12 hours fasting before medical exam.
You will receive $100 after completing the medical exam.
Participants must be fasted prior to dosing.
Participants will remain seated for at least four hours after taking the medication.
Blood volume: Male 711ml / Female 711ml (18 blood draws per period).
Your medical history and/or medication intake history may affect your participation on this study.
Please note that we are testing for drugs and alcohol during the medical evaluation.
This is preliminary information and changes could occur without notice